The New B eathite ol Sp ay fo mulatio combi es mullei leaf ext act, gi ge oot ext act, a d o ga ic lemo ext act i a liquid dieta y suppleme t i te ded fo adults i te ested i espi ato y well ess.
The i t oductio of B eathite ol eflects the co ti ued developme t of dieta y suppleme t fo mulatio s usi g pla t-de ived i g edie ts. The fo mulatio b i gs togethe bota icals with diffe e t histo ies of t aditio al use a d scie tific i vestigatio , although the p ese ce of these i g edie ts does ot establish that the fi ished p oduct imp oves lu g fu ctio o t eats espi ato y co ditio s.
B eathite ol is positio ed withi the dieta y suppleme t catego y athe tha as a p esc iptio medicatio o a t eatme t fo espi ato y disease. Its fo mulatio emphasizes bota ical i g edie ts, with the i dividual compo e ts selected fo thei established ide tities a d histo ical use i he bal p epa atio s.
The a ou ceme t p ovides a oppo tu ity to exami e the compositio of B eathite ol Sp ay, the cha acte istics of its i g edie ts, a d the scie tific co side atio s eleva t to espi ato y well ess suppleme ts.
B eathite ol Sp ay uses a liquid delive y fo mat, disti guishi g its physical p ese tatio f om co ve tio al tablets a d capsules. Howeve , a sp ay fo mat does ot by itself establish imp oved abso ptio , effective ess, o bioavailability.
The B eathite ol fo mulatio b i gs togethe bota ical mate ials that have appea ed i t aditio al he bal p actices a d mode dieta y suppleme t esea ch.
Acco di g to the supplied i g edie t desc iptio , B eathite ol co tai s:
Mullei ( Ve bascum thapsus ) leaf ext act 10:1: A co ce t ated bota ical p epa atio de ived f om mullei leaves.Gi ge ( Zi gibe offici ale ) oot ext act: A ext act obtai ed f om gi ge , a pla t widely used i food a d t aditio al he bal p epa atio s.O ga ic lemo ext act: A cit us-de ived i g edie t i cluded i the bota ical fo mulatio .
These i g edie ts ep ese t the stated compositio of B eathite ol Sp ay. Thei i dividual i clusio should ot be i te p eted as p oof that the combi atio p oduces a pa ticula cli ical outcome.
Respi ato y health i volves the coo di ated fu ctio i g of the lu gs, ai ways, espi ato y muscles, a d othe st uctu es espo sible fo excha gi g oxyge a d ca bo dioxide.
The espi ato y system is exposed to e vi o me tal facto s, i cludi g ai bo e pa ticles, alle ge s, pollutio , a d i fectious age ts. Mai tai i g espi ato y well ess i volves multiple co side atio s, such as avoidi g tobacco smoke, educi g exposu e to ha mful polluta ts, stayi g physically active, a d obtai i g app op iate medical ca e.
Although B eathite ol i cludes i g edie ts associated with t aditio al he bal use, dieta y suppleme ts should ot be ega ded as substitutes fo evide ce-based espi ato y ca e.
Ch o ic coughi g, wheezi g, sho t ess of b eath, a d pe siste t chest discomfo t ca i dicate medical co ditio s equi i g p ofessio al assessme t.
B eathite ol Sp ay should ot be p ese ted as a t eatme t fo asthma, ch o ic obst uctive pulmo a y disease, b o chitis, p eumo ia, o othe espi ato y ill esses without app op iate cli ical evide ce a d egulato y autho izatio .
Mullei , scie tifically ide tified as Ve bascum thapsus, is a flowe i g pla t fou d i va ious egio s of Eu ope, Asia, a d No th Ame ica.
Its leaves a d flowe s have appea ed i t aditio al he bal p epa atio s fo ge e atio s. Histo ical he bal efe e ces desc ibe mullei as a pla t used i p epa atio s associated with th oat a d espi ato y comfo t.
B eathite ol i co po ates mullei leaf ext act with a stated ext actio atio of 10:1.
This atio ge e ally desc ibes the elatio ship betwee the qua tity of sta ti g pla t mate ial a d the esulti g ext act. It does ot i depe de tly establish the co ce t atio of specific active compou ds o the cli ical effective ess of the i g edie t.
Mullei co tai s seve al classes of atu ally occu i g pla t compou ds, i cludi g flavo oids, phe olic substa ces, a d othe phytochemicals.
Scie tific i vestigatio s have exami ed some of these co stitue ts i labo ato y setti gs. Howeve , labo ato y fi di gs ca ot automatically be t a slated i to demo st ated be efits fo huma lu g fu ctio .
The i clusio of mullei i B eathite ol Sp ay eflects the pla t’s histo ical associatio with espi ato y he bal p epa atio s.
Fu the esea ch would be ecessa y to dete mi e whethe a specific mullei ext act, at a defi ed dosage, p oduces measu able espi ato y be efits i huma s.
Gi ge , k ow bota ically as Zi gibe offici ale, is a widely cultivated pla t whose u de g ou d stem, commo ly called gi ge oot, is used i culi a y a d t aditio al he bal applicatio s.
Gi ge co tai s atu ally occu i g compou ds such as gi ge ols a d shogaols. These substa ces have bee i vestigated fo va ious biological p ope ties i expe ime tal esea ch.
B eathite ol i cludes gi ge oot ext act as the seco d ide tified bota ical i g edie t.
Some labo ato y a d p ecli ical studies have explo ed gi ge -de ived compou ds i elatio to i flammato y pathways a d smooth muscle espo ses. Such fi di gs emai disti ct f om cli ical evide ce demo st ati g espi ato y be efits i people usi g a pa ticula suppleme t.
B eathite ol Sp ay combi es gi ge ext act with mullei a d lemo ext acts, but the scie tific effects of this exact combi atio ca ot be established f om esea ch o gi ge alo e.
The qua tity, ext actio method, a d chemical sta da dizatio of gi ge ext act ca i flue ce the compositio of a fi ished fo mulatio .
I fo matio about the p ecise gi ge co ce t atio i
Gi ge ca also cause gast oi testi al discomfo t i some i dividuals a d may wa a t additio al cautio fo people taki g ce tai medicatio s, i cludi g a ticoagula ts.
Lemo , scie tifically classified as Cit us limo , is widely used i foods, beve ages, a d bota ical p epa atio s.
Lemo -de ived ext acts ca co tai diffe e t combi atio s of cit us compou ds depe di g o the pla t mate ial a d ma ufactu i g p ocess used.
B eathite ol i co po ates o ga ic lemo ext act as its thi d stated i g edie t.
The desig atio “o ga ic” ge e ally elates to ag icultu al p oductio a d ce tificatio sta da ds. It does ot i depe de tly establish that a i g edie t has g eate the apeutic effective ess o is f ee f om pote tial adve se eactio s.
Lemo co tai s atu ally occu i g substa ces, i cludi g cit ic acid a d va ious pla t compou ds. Howeve , the compositio of a lemo ext act ca diffe substa tially f om that of f esh lemo juice o whole f uit.
B eathite ol Sp ay i cludes lemo ext act withi its th ee-bota ical fo mulatio .
The i g edie t’s p ecise co t ibutio to the fi ished p oduct ca ot be dete mi ed without i fo matio about its qua tity, chemical compositio , a d i te ded fo mulatio ole.
Resea ch i volvi g cit us compou ds should ot be i te p eted as di ect evide ce that B eathite ol imp oves b eathi g o espi ato y fu ctio .
B eathite ol combi es th ee bota ical ext acts i a liquid suppleme t fo mat.
The fo mulatio i cludes i g edie ts with diffe e t bota ical o igi s a d chemical cha acte istics. Mullei co t ibutes leaf-de ived compou ds, gi ge p ovides oot-de ived co stitue ts, a d lemo supplies cit us-de ived mate ial.
B eathite ol Sp ay is ide tified as a sp ay, but the supplied p oduct i fo matio does ot establish whethe it is i te ded fo o al, subli gual, o a othe oute of admi ist atio .
This disti ctio matte s because admi ist atio outes affect labeli g equi eme ts, app op iate use, a d safety co side atio s.
The p ese ce of multiple bota ical ext acts also does ot ecessa ily mea that the i g edie ts wo k togethe sy e gistically.
Claims of sy e gy equi e esea ch demo st ati g that the combi ed fo mulatio p oduces effects beyo d those of its i dividual compo e ts.
Fo B eathite ol, o p oduct-specific cli ical t ial esults have bee supplied to establish such a i te actio .
A assessme t of the complete fo mulatio would equi e additio al i fo matio about ext act qua tities, se vi g size, othe i g edie ts, ma ufactu i g co t ols, a d fi ished-p oduct testi g.
Respi ato y well ess is a b oad co cept. It ca efe to mai tai i g o mal physiological fu ctio , suppo ti g healthy habits, o add essi g e vi o me tal facto s that affect b eathi g.
B eathite ol Sp ay is desc ibed as a suppleme t fo espi ato y suppo t, but that desc iptio should ot be i te p eted as evide ce of cli ically demo st ated imp oveme ts i lu g capacity, oxyge excha ge, o ai way fu ctio .
I the U ited States, dieta y suppleme ts a e egulated u de a f amewo k disti ct f om the p ema ket app oval system used fo pha maceutical d ugs.
Ma ufactu e s a e espo sible fo e su i g that thei p oducts comply with applicable safety, ma ufactu i g, a d labeli g equi eme ts.
Ce tai st uctu e/fu ctio claims may be pe mitted whe app op iately substa tiated a d accompa ied by equi ed labeli g stateme ts. Claims to diag ose, t eat, cu e, o p eve t disease a e subject to diffe e t egulato y equi eme ts.
B eathite ol should the efo e be desc ibed usi g la guage co siste t with its egulato y classificatio a d available suppo ti g evide ce.
I g edie t t a spa e cy is a impo ta t co side atio whe evaluati g a y multi-i g edie t dieta y suppleme t.
B eathite ol ide tifies its th ee p i cipal bota ical ext acts, p ovidi g a sta ti g poi t fo u de sta di g the fo mulatio .
Howeve , a complete p oduct assessme t would also equi e i fo matio about se vi g qua tities, ext act specificatio s, i active i g edie ts, a d ecomme ded use.
Fo B eathite ol Sp ay, the stated 10:1 mullei ext actio atio desc ibes o e aspect of the i g edie t but does ot eplace a qua titative decla atio of the ext act amou t.
Co sume s a d healthca e p ofessio als may also eed to k ow whethe bota ical i g edie ts a e sta da dized to pa ticula compou ds.
Ma ufactu i g quality co side atio s i clude i g edie t ide tity ve ificatio , co tami atio testi g, mic obiological co t ols, a d complia ce with applicable ma ufactu i g equi eme ts.
Such i fo matio ca help disti guish the decla ed compositio of a suppleme t f om assumptio s about its pu ity o effective ess.
Bota ical esea ch i volves seve al levels of i vestigatio , i cludi g labo ato y expe ime ts, a imal studies, obse vatio al esea ch, a d co t olled huma cli ical t ials.
These fo ms of evide ce a swe diffe e t scie tific questio s a d ca ot be t eated as i te cha geable.
Fo B eathite ol, esea ch co ce i g i dividual pla t i g edie ts may p ovide backg ou d i fo matio about thei chemical co stitue ts a d t aditio al applicatio s.
It does ot establish that the fi ished fo mulatio p oduces a cli ically mea i gful espi ato y be efit.
Huma studies would be eeded to evaluate specific outcomes such as cha ges i espi ato y symptoms, lu g-fu ctio measu eme ts, o othe app op iately defi ed health i dicato s.
Such studies would also eed to co side dosage, pa ticipa t cha acte istics, study du atio , compa iso g oups, a d pote tial adve se effects.
No completed cli ical t ials evaluati g B eathite ol Sp ay we e supplied fo this a ou ceme t.
Co seque tly, stateme ts about the fo mulatio should emai limited to its docume ted compositio , i te ded p oduct catego y, a d ge e al bota ical backg ou d.
Bota ical i g edie ts ca have physiological effects a d may i te act with medici es o existi g medical co ditio s.
B eathite ol co tai s multiple pla t ext acts, maki g app op iate labeli g a d i g edie t disclosu e impo ta t.
I dividuals with alle gies to a y listed i g edie ts should avoid exposu e to those substa ces.
People who a e p eg a t, b eastfeedi g, ma agi g ch o ic medical co ditio s, o taki g p esc iptio medici es should seek p ofessio al medical guida ce befo e usi g u familia suppleme ts.
B eathite ol Sp ay should also be used o ly acco di g to ve ified p oduct i st uctio s, pa ticula ly because the i te ded admi ist atio oute has ot bee co fi med i the supplied i fo matio .
People expe ie ci g b eathi g difficulty, pe siste t wheezi g, chest pai , o wo se i g espi ato y symptoms should seek medical evaluatio athe tha elyi g o dieta y suppleme ts.
Seve e b eathi g difficulty equi es u ge t medical atte tio .
Respi ato y well ess depe ds o multiple facto s beyo d dieta y suppleme t use.
Public health guida ce ge e ally emphasizes avoidi g smoki g a d seco dha d smoke, educi g exposu e to ha mful ai bo e substa ces, mai tai i g app op iate physical activity, a d followi g ecomme ded p eve tive healthca e p actices.
B eathite ol is positio ed as a bota ical suppleme t withi this wide well ess co text.
No evide ce has bee p ovided establishi g that B eathite ol Sp ay ca eplace these p eve tive measu es o medically ecomme ded t eatme ts.
A bala ced u de sta di g of espi ato y well ess ecog izes that bota ical i g edie ts may be subjects of scie tific i te est while still equi i g igo ous evaluatio befo e specific health outcomes ca be claimed.
B eathite ol Sp ay is p ese ted as a dieta y suppleme t fo ge e al espi ato y well ess suppo t. This i te ded positio i g does ot establish that the p oduct imp oves lu g fu ctio o t eats espi ato y diseases.
The th ee ide tified i g edie ts a e mullei (Ve bascum thapsus) leaf ext act 10:1, gi ge (Zi gibe offici ale) oot ext act, a d o ga ic lemo ext act.
Mullei has a histo y of use i t aditio al he bal p epa atio s associated with espi ato y comfo t. Its i clusio does ot i depe de tly establish cli ical effective ess.
Gi ge co tai s atu ally occu i g compou ds that have bee studied i labo ato y a d othe esea ch setti gs. Evide ce about i dividual gi ge compou ds does ot establish the effective ess of the fi ished fo mulatio .
O ga ic lemo ext act p ovides a cit us-de ived compo e t. Its specific fu ctio al co t ibutio has ot bee established f om the supplied p oduct i fo matio .
No p oduct-specific huma cli ical t ial data have bee p ovided. Resea ch i volvi g i dividual i g edie ts should ot be ep ese ted as cli ical validatio of the complete fo mulatio .
B eathite ol Sp ay has ot bee established as a t eatme t fo asthma, ch o ic obst uctive pulmo a y disease, o othe espi ato y co ditio s. People with diag osed espi ato y ill esses should follow guida ce f om qualified healthca e p ofessio als.
The ecomme ded se vi g size, f eque cy, a d admi ist atio oute have ot bee p ovided. Use s should co sult ve ified p oduct labeli g befo e use.
Complete Suppleme t Facts labeli g, i g edie t qua tities, ma ufactu i g i fo matio , safety wa i gs, a d substa tiatio fo a y p oduct-specific claims would suppo t a mo e comp ehe sive assessme t.
The i t oductio of
B eathite ol Sp ay combi es mullei leaf ext act, gi ge oot ext act, a d o ga ic lemo ext act i a liquid p oduct p ese ted fo ge e al espi ato y well ess.
The a ou ceme t ide tifies the fo mulatio ‘s p i cipal bota ical compo e ts while disti guishi g thei t aditio al applicatio s f om cli ically demo st ated outcomes.
Fu the disclosu e of i g edie t qua tities, ma ufactu i g specificatio s, admi ist atio i st uctio s, a d p oduct-specific esea ch would p ovide additio al i fo matio fo evaluati g the fo mulatio .
As with othe dieta y suppleme ts, B eathite ol should be co side ed withi the co text of app op iate medical ca e, established espi ato y health p actices, a d the available scie tific evide ce.
CONTACT: Suppo t: +1 (855) 889-3137
Email Suppo t: co tact@custome cs.com
